Biocon Biologics to Acquire Viatris’ Biosimilars Assets For $ 3.335 Billion
▪ Biocon Biologics Limited’s (BBL) acquisition of Viatris’ rights in biosimilars assets,…
Search
Have an existing account?
Sign In
Tag: Viatris
